Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study checks if popular eye drops really soothe dry eyes

NCT ID NCT07540884

Symptom relief Sponsor: Alcon Research Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 26, 2026 · Updated 5 times

Summary

This study is testing two versions of Tears Naturale lubricating eye drops—one with preservatives and one without—in 120 people with mild to moderate dry eye disease. Participants will stop using their usual artificial tears and use only the study drops for the duration of the trial. The main goal is to see if the drops reduce how much dry eye symptoms bother people in daily life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
lubricating eye drops (dextran 70 and hypromellose)
What this could lead to
If successful, this study could confirm that these eye drops safely relieve dry eye symptoms in everyday use.
What could go wrong
This is a small, post-market study, not a large trial. The drops are already available, so the results may not show major new benefits. Some people may still experience irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: * Able to read, understand, and sign an Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved informed consent form in English or French. * Able to attend all study visits as required as per protocol. * Mild to moderate dry eye disease. * Willing to discontinue use of all habitual artificial tear supplements and use only the study device for the entire study duration. * Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: * Any known allergic reactions to the study products or its ingredients. * Ocular injury to either eye in the past 3 months prior to screening. * Ocular surgery within the previous 6 months or ocular surgery planned during the study. * Use of any systemic medication known to cause dry eye for less than 1 month before the Screening/Baseline visit. * Other protocol-defined exclusion criteria may apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dry eye disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dry eye disease

Contacts and locations

Locations

  • Dr. Shalu Pal & Associates

    Toronto, Ontario, M5R 2A5, Canada

  • Eyes on Sheppard

    North York, Ontario, M2N 3A1, Canada

  • Hopital de Chicoutimi and LASIK MD

    Chicoutimi, Quebec, G7H 7W8, Canada

  • Institut de L'Oeil des Laurentides

    Boisbriand, Quebec, J7H 0E8, Canada

  • Integra Eyecare Centre

    Burnaby, British Columbia, V5E 1G3, Canada

  • The Medical Arts Health Research Group

    Kelowna, British Columbia, V1Y 4N7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.